Rajendran Dhivya, Bandhu Rajiv, Gautam Sujata, K Dhamija Rajinder, Mondal Sunita
Department of Physiology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, IND.
Department of Neurology, Institute of Human Behaviour and Allied Sciences, New Delhi, IND.
Cureus. 2023 Sep 25;15(9):e45933. doi: 10.7759/cureus.45933. eCollection 2023 Sep.
Parkinson's disease (PD) is the second most common neurodegenerative disorder. Though the cardinal features of PD are motor symptoms, it is also associated with many non-motor symptoms, such as cognitive impairment, autonomic dysfunction, sleep disorders, and depression, which could affect the quality of life. Early identification of PD's non-motor signs can aid in the diagnosis of PD. The current research aimed to assess the neurophysiological changes in PD patients using auditory evoked P300 potential and to determine the possible correlation between P300 wave components and cognitive impairment.
This cross-sectional research involved 32 idiopathic PD patients. The neurophysiological changes in PD patients were studied using auditory evoked P300 potential and the obtained data were compared with normative data. The patient's cognitive status was scored using the Montreal Cognitive Assessment (MoCA) questionnaire and they were divided into two groups: the patients with normal cognition and the patients with impaired cognition.
The participants showed a significant decrease in P300 amplitude (p = 0.000) but no change in P300 latency when compared to normative data using the Wilcoxon rank sum test. Also, there was a positive correlation between the MoCA score and P300 amplitude (p < 0.05), indicating that if cognition is impaired, P300 amplitude would also be reduced. There was a significant difference between PD patients with impaired cognition and patients with normal cognition in the P300 amplitude at Cz (p = 0.001) and Fz (p = 0.003) when the Mann-Whitney U test was used. These findings indicate that it is possible to notice changes in the P300 wave components among PD patients when their cognition is impaired.
Auditory evoked P300 potentials can be used to objectively evaluate cognition in PD patients and by starting supportive therapy, the quality of life for PD patients can be improved.
帕金森病(PD)是第二常见的神经退行性疾病。尽管PD的主要特征是运动症状,但它也与许多非运动症状相关,如认知障碍、自主神经功能障碍、睡眠障碍和抑郁,这些都会影响生活质量。早期识别PD的非运动体征有助于PD的诊断。当前研究旨在使用听觉诱发P300电位评估PD患者的神经生理变化,并确定P300波成分与认知障碍之间的可能相关性。
这项横断面研究纳入了32例特发性PD患者。使用听觉诱发P300电位研究PD患者的神经生理变化,并将获得的数据与正常数据进行比较。使用蒙特利尔认知评估(MoCA)问卷对患者的认知状态进行评分,并将他们分为两组:认知正常的患者和认知受损的患者。
与正常数据相比,使用Wilcoxon秩和检验时,参与者的P300波幅显著降低(p = 0.000),但P300潜伏期无变化。此外,MoCA评分与P300波幅之间存在正相关(p < 0.05),表明如果认知受损,P300波幅也会降低。使用Mann-Whitney U检验时,认知受损的PD患者与认知正常的患者在Cz(p = 0.oooo1)和Fz(p = 0.003)处的P300波幅存在显著差异。这些发现表明,当PD患者认知受损时,可以注意到其P300波成分的变化。
听觉诱发P300电位可用于客观评估PD患者的认知,通过开展支持性治疗,可以提高PD患者的生活质量。